Back to top
more

AMN Healthcare Services (AMN)

(Real Time Quote from BATS)

$42.64 USD

42.64
554,284

+0.01 (0.02%)

Updated Sep 27, 2024 03:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 35% (164 out of 251)

Industry: Medical Services

Better trading starts here.

Zacks News

Here's Why You Should Add Glaukos (GKOS) to Your Portfolio

Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.

Vasundhara Sawalka headshot

4 Stocks Trading Near 52-Week High That Can Scale Higher

Investors target stocks that have been on a bullish run lately. Stocks like AMN, OTTR, ECPG and CBOE that are seeing price strength have a high chance of carrying the momentum forward.

Zacks.com featured highlights include JSanderson Farms, Otter Tail, J&J Snack Foods and AMN Healthcare

JSanderson Farms, Otter Tail, J&J Snack Foods and AMN Healthcare are part of Screen of the Week article.

Reasons to Retain AmerisourceBergen (ABC) in Your Portfolio

AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.

Here's Why You Should Retain Walgreens Boots (WBA) For Now

Investors are optimistic about Walgreens Boots (WBA), given its better-than-expected earnings and strategic alliances.

Cardinal Health's (CAH) New Buyout to Boost Medication Adherence

Cardinal Health's (CAH) latest acquisition is expected to significantly improve patients' health outcomes with improved medication adherence and increased satisfaction.

Nilanjan Banerjee headshot

Buy These 4 Low-Beta Stocks to Sail Through a Volatile Market

It is imperative to build a portfolio of low-beta stocks to sail through a choppy market. Sanderson (SAFM), Otter Tail (OTTR), J&J Snack Foods (JJSF) and AMN Healthcare (AMN) are well poised to gain.

Here's Why You Should Hold on to CONMED (CNMD) Stock Now

CONMED (CNMD) continues to gain momentum from a solid product portfolio and a strong General Surgery business. However, data security issues linger.

Factors that Make Acadia Healthcare (ACHC) an Attractive Bet Now

Solid demand for behavioral healthcare services, growth-related efforts in the form of JVs, declining debt burden and sufficient cash-generating abilities continue to benefit Acadia Healthcare (ACHC).

Henry Schein's (HSIC) New Buyout Expands Its Switzerland Base

Henry Schein (HSIC) serves the Swiss dental implant market through its Basel-based division, Camlog Biotechnologies GmbH, since 2004.

Merit Medical's (MMSI) New Launch to Improve Patient Outcome

Merit Medical's (MMSI) latest launch will likely aid in precisely targeting affected tissues, thereby resulting in more successful surgeries and improved patient outcomes.

Reasons to Retain Merit Medical (MMSI) Stock in Your Portfolio

Investors continue to be optimistic about Merit Medical (MMSI) owing to its strong product portfolio.

Quest Diagnostics (DGX), CDC Sign New COVID-19 Testing Deal

Quest Diagnostics (DGX) and the CDC tie up to provide COVID testing for underserved communities free of cost across the United States.

LabCorp's (LH) Base Testing Volume Grows, Costs Rise

LabCorp's (LH) slew of product launches and collaborations to pursue short- and long-term high-growth opportunities instill optimism.

Here's Why You Should Retain Haemonetics (HAE) Stock For Now

Investors are optimistic about Haemonetics' (HAE) robust performances across the Hospital and Plasma businesses.

3 Reasons to Retain Avanos (AVNS) Stock in Your Portfolio

Investors continue to be optimistic about Avanos (AVNS) owing to its strong product line and focus on R&D.

Bruker (BRKR) Debuts NMR Test for Research on Long COVID Risks

Bruker's (BRKR) PhenoRisk PACS RuO will facilitate clinical research to combat the risks of Long COVID syndrome.

Cardinal Health (CAH) Buys Bendcare CPO-GPO, Invests in Its MSO

Cardinal Health's (CAH) latest acquisition is expected to significantly boost its distribution opportunities and improve patient service.

LabCorp (LH) to Offer Monkeypox Test, Double CDC's Capacity

Labcorp (LH) is set to become the first national laboratory to offer this PCR test, verified for the CDC.

AMN Healthcare Services (AMN) Stock Sinks As Market Gains: What You Should Know

AMN Healthcare Services (AMN) closed the most recent trading day at $110.47, moving -0.11% from the previous trading session.

Here's Why You Should Retain Edwards Lifesciences (EW) Now

Investors are optimistic about Edwards Lifesciences' (EW) strong segmental performance and the growing demand for its RESILIA tissue valves.

Reasons Why You Should Invest in ResMed (RMD) Stock Now

Investors are optimistic about ResMed's (RMD) robust mask and device sales and continued product innovations.

3 Reasons to Retain Baxter (BAX) Stock in Your Portfolio

Investors remain optimistic about Baxter (BAX) due to its strong product portfolio.

Study Favors Masimo's (MASI) SafetyNet for Better Patient Outcome

Masimo's (MASI) SafetyNet is expected to reduce the duration of hospitalization for COVID-19 patients and create more bed capacity in hospitals.

Tandem Diabetes (TNDM) New Launches Aid Growth Amid Cost Woes

Tandem Diabetes (TNDM) witnesses strong customer retention, driven by the impressive positive response from the Control-IQ technology.